ODM-111
/ Orion Corp, Jemincare
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
April 16, 2024
JMKX0623-201: Evaluate the Efficacy and Safety of JMKX000623 in Participants With Diabetic Peripheral Neuropathic Pain
(clinicaltrials.gov)
- P2 | N=220 | Recruiting | Sponsor: Jemincare | Not yet recruiting ➔ Recruiting
Enrollment open • Diabetic Neuropathy • Neuralgia • Pain • Peripheral Neuropathic Pain
April 16, 2024
A DDI Study of JMKX000623 and Metformin Hydrochloride
(clinicaltrials.gov)
- P1 | N=24 | Completed | Sponsor: Jemincare | Active, not recruiting ➔ Completed
Trial completion
January 24, 2024
Evaluate the Efficacy and Safety of JMKX000623 in Participants With Diabetic Peripheral Neuropathic Pain
(clinicaltrials.gov)
- P2 | N=220 | Not yet recruiting | Sponsor: Jemincare
New P2 trial • Diabetic Neuropathy • Neuralgia • Pain • Peripheral Neuropathic Pain
October 04, 2023
A DDI Study of JMKX000623 and Metformin Hydrochloride
(clinicaltrials.gov)
- P1 | N=24 | Active, not recruiting | Sponsor: Jemincare
New P1 trial
1 to 4
Of
4
Go to page
1